It Kills That: Cramer Won’t Recommend Pfizer 7% Yield
Jim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
Identify where to find high risk investments that offer potential for high returns. Explore various avenues to enhance your portfolio.
27,969 articlesJim Cramer declines to back Pfizer despite its 7% dividend, arguing the growth case isn’t clear. Pfizer sits near a 5...
A small AI-focused player claims it helps customers turn modest marketing spend into impressive gains. This piece bre...
Instagram will notify parents in its supervision program when their teens search suicide- or self-harm-related terms,...
NeoCloud stocks jumped on renewed AI compute optimism, led by IREN and CoreWeave, while Mara posted strong momentum l...
GRNY beats COWZ by 11 points this year, signaling a tilt toward AI, electrification, and energy themes. Oil prices an...
A highly focused 3x Korea fund rides a memory-chip demand wave to striking gains, but risk factors and regulatory scr...
SpaceX's market debut ignited a wave of aggressive bets on disruptive ideas. Investors pile into moonshot bets as opt...
May 2026 delivered a dramatic uptick in tokenized pre-IPO trading, led by SpaceX as the Nasdaq listing approached, wi...
Super Micro Computer stock tumbled 29% in a month as Dell and HPE rally on AI growth. Analysts weigh whether investor...
NVIDIA just revealed owns a notable minority stake in Nebius, triggering a sharp stock move. This article breaks down...
A major shift in ServiceNow's strategy, led by aggressive AI integration and larger enterprise contracts, could set t...
Markets showed modest gains as the Fed meeting kicked off, with tech and travel shares helping lift indexes. This gui...